A shocking revelation about dementia patients and their medication has come to light. Despite medical guidelines warning against it, brain-altering drugs linked to falls, confusion, and hospitalizations are still being prescribed to those with dementia. A recent study published in JAMA reveals that one in four Medicare beneficiaries with dementia are receiving these medications.
While there has been a slight decline in overall prescribing rates for these drugs, the study highlights a concerning trend. People with cognitive impairment, who are more susceptible to adverse effects, continue to receive these medications at higher rates.
Dr. John N. Mafi, a senior author of the study, emphasizes the need for improvement: "Over two-thirds of patients receiving these prescriptions lacked a documented clinical indication, suggesting inappropriate prescribing. We must address this issue to enhance the quality and safety of care for older Americans."
The study analyzed survey data and Medicare claims, focusing on five categories of central nervous system (CNS)-active medications. It found that these medications were prescribed to 17% of older adults with normal cognition, 22% of those with cognitive impairment, and a concerning 25% of individuals with dementia.
But here's where it gets controversial... The prescribing trends varied by medication type. While benzodiazepines and sleep medications saw a decline, antipsychotic prescriptions increased.
The researchers acknowledge limitations, such as missing clinical details and not including Medicare Advantage data. However, they emphasize the importance of close collaboration between patients, caregivers, and physicians to ensure appropriate medication use.
Dr. Annie Yang, who led the study, advises, "When inappropriate, patients and their care teams should explore alternative treatments and consider tapering or stopping these medications."
This study, co-authored by a team of experts, sheds light on a critical issue and invites further discussion. So, what are your thoughts? Do you think enough is being done to address this problem? Feel free to share your insights in the comments!
